Current Hematologic Malignancy Reports

期刊简介：his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy.We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.

【译文】该期刊旨在通过国际专家的清晰、深刻、平衡的贡献，回顾与血液恶性肿瘤的诊断、治疗、管理和预防相关的最新临床发现。我们通过任命国际权威人士担任关键领域的部门编辑，如白血病、淋巴瘤、骨髓瘤和T细胞及其他淋巴增殖性恶性肿瘤，来实现这一目标。部门编辑随后选择主题，由领先的专家撰写全面综述文章，强调新发展和最近发表的具有重大重要性的论文，并附有注释参考文献列表。国际编委会审查年度目录，建议对其国家/地区特别感兴趣的文章，并确保主题是当前的，包括新兴研究。该领域知名人士的评论也一并提供。